When the pandemic started last year, Yokogawa decided to collaborate with research projects worldwide with the aim to better understand SARS-CoV-2 infection. This blog post highlights the Covid-19 research of MD Ph.D. Yohei Yamauchi and his working group, University of Bristol, England.
Host cell entry of SARS-CoV-2 and Influenza virus Read More »
When the pandemic started last year, Yokogawa decided to collaborate with research projects worldwide with the aim to better understand SARS-CoV-2 infection. This article highlights the Covid-19 research of Dr. Giuseppe Balistreri and his working group, University of Helsinki, Finland.
High-Content Analysis: Understanding SARS-CoV-2 infection of cells Read More »
For more than one year the world struggles with the severe acute respiratory syndrome (SARS) caused by a single-stranded RNA pathogen SARS coronavirus 2 (SARS-CoV-2). The World Health Organization (WHO) categorized in March 2020 Covid-19 disease as a pandemic. SARS-CoV-2 can cause acute and chronic respiratory and central nervous system illnesses. How can researchers use genomic sequencing to get more insights into the deadly virus?
Genomic Sequencing: Tracking of different mutant SARS-CoV-2 strains Read More »
Yokogawa decided to support the world’s fight against COVID-19, scientifically cooperating with research facilities actively involved in COVID-19 research. In those global collaborations, researchers will use the Yokogawa bench-top confocal quantitative image cytometer – the CellVoyager CQ1 microscope.
Yokogawa supports COVID-19 research at the Charité in Berlin Read More »
